- Home
- PBT vs NBTX Comparison
PBT vs NBTX Comparison
Compare PBT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBT | NBTX |
|---|---|---|
| Founded | 1980 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.1M | 1.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PBT | NBTX |
|---|---|---|
| Price | $18.96 | $21.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 95.9K | 52.5K |
| Earning Date | 01-01-0001 | 09-30-2025 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $17,266,423.00 | $11,930,711.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $136.64 |
| P/E Ratio | $56.92 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.01 | $2.76 |
| 52 Week High | $20.46 | $30.35 |
Technical Indicators
Market Signals| Indicator | PBT | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 51.82 |
| Support Level | $17.13 | $20.05 |
| Resistance Level | $19.37 | $22.05 |
| Average True Range (ATR) | 0.78 | 0.92 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 58.93 | 61.54 |
Price Performance
Historical ComparisonAbout PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.